Researcher from Instituto de Investigacion Hospital 12 de Octubre Describes Findings in Nephropathy (Targeting complement in IgA nephropathy).

A recent report from researchers at Instituto de Investigacion Hospital 12 de Octubre in Madrid, Spain, discusses the role of complement activation in immunoglobulin A nephropathy (IgAN), the most common primary glomerulonephritis worldwide. The study highlights the significant advancements in understanding the pathogenesis of IgAN and the role of complement activation in the disease. The researchers also discuss the potential of complement inhibitors as a treatment option for IgAN and mention ongoing trials evaluating the efficacy of new agents targeting different components of the complement pathway. This comprehensive review provides valuable insights into the potential development of new therapies for IgAN. [Extracted from the article]